Based on the ODI PHARMA AB stock forecast from 0 analysts, the average analyst target price for ODI PHARMA AB is not available over the next 12 months. ODI PHARMA AB’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ODI PHARMA AB is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, ODI PHARMA AB’s stock price was EUR 0.20. ODI PHARMA AB’s stock price has changed by -8.93% over the past week, -12.07% over the past month and -49.50% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for 6OD:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
